{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:03:11Z","timestamp":1789592591280,"version":"build-2803163510"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jcf.2026.09.005","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:12:22Z","timestamp":1789384342000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the impact of elexacaftor\/tezacaftor\/ivacaftor on work productivity and activity impairment in people living with cystic fibrosis in Canada"],"prefix":"10.1016","author":[{"given":"Grace G","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rayment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Bilodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry C.","family":"Lands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Y.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Ratjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1785-3870","authenticated-orcid":false,"given":"Bradley S.","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcf.2026.09.005_bib0001","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1378\/chest.14-1997","article-title":"The evolution of Cystic fibrosis care","volume":"148","author":"Pittman","year":"2015","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.jcf.2026.09.005_bib0002","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.chpulm.2024.100077","article-title":"A dramatic decline in lung transplantation for cystic fibrosis in the United States","volume":"2","author":"Milinic","year":"2024","journal-title":"CHEST Pulm"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.005_bib0004","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40273-020-00986-4","article-title":"Use of productivity loss\/gain in cost-effectiveness analyses for drugs: a systematic review","volume":"39","author":"Yuasa","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.005_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.005_bib0006","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12890-019-0887-6","article-title":"Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study","volume":"19","author":"Bell","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.005_bib0007","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","article-title":"Development and validation of the cystic fibrosis questionnaire in the united states: a health-related quality-of-life measure for cystic fibrosis","volume":"128","author":"Quittner","year":"2005","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.jcf.2026.09.005_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182211776","article-title":"Employment status and work ability in adults with cystic fibrosis","volume":"18","author":"Leso","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.005_bib0009","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcf.2021.08.011","article-title":"The impact of cystic fibrosis on the working life of patients: a systematic review","volume":"21","author":"Leso","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.005_bib0010","article-title":"Socioeconomic burden of cystic fibrosis in Canada","volume":"11","author":"Laflamme","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jcf.2026.09.005_bib0011","unstructured":"Chavez, L., Steele, K., Wong, D., Yung, I., Johnson, N., Laflamme, O.D., Adams, J., Cheng, S.Y., Rabin, H., Quon, B.S., Sadatsafavi, M., Stephenson, A.L., Wranik, D., Eckford, P., & Wallenburg, J. (2026). How has widespread access to CFTR modulator therapy changed the socio-economic burden of cystic fibrosis in Canada? [Manuscript submitted for publication.]."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:06:20Z","timestamp":1789589180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326037392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":11,"alternative-id":["S1569199326037392"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the impact of elexacaftor\/tezacaftor\/ivacaftor on work productivity and activity impairment in people living with cystic fibrosis in Canada","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}